The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2017
DOI: 10.1038/ncomms15794
|View full text |Cite
|
Sign up to set email alerts
|

Correction: Corrigendum: An extra-uterine system to physiologically support the extreme premature lamb

Abstract: Nature Communications 8: Article number: 15112 (2017); Published 25 April 2017; Updated 23 May 2017 A patent based on the work reported in this Article was inadvertently omitted from the Competing interests section of this article. The Competing interests statement should read: E.M., A.F. and M.D. are co-authors on a patent entitled ‘Extracorporeal life support system and methods of use thereof’ (Patent no.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
18
0

Year Published

2019
2019
2021
2021

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 25 publications
(18 citation statements)
references
References 0 publications
0
18
0
Order By: Relevance
“…The artificial womb, confirmed as beneficial for premature babies, is another possible solution for allowing the myocardium enough time to adapt to the extrauterine conditions (175). Whether this technique would also be of assistance in term neonates with severe PA, remains a question for further research.…”
Section: Discussion Of Future Directionsmentioning
confidence: 99%
“…The artificial womb, confirmed as beneficial for premature babies, is another possible solution for allowing the myocardium enough time to adapt to the extrauterine conditions (175). Whether this technique would also be of assistance in term neonates with severe PA, remains a question for further research.…”
Section: Discussion Of Future Directionsmentioning
confidence: 99%
“…New methods for extracorporeal life support for the premature are in development. The artificial placenta (AP) focuses on support in the extremely premature (23–28 weeks gestational age, GA) (4244). To predict the volume of extremely prematurely born infants to be offered AP, or the spread of this life support mode and the extent of engagement by mobile ECMO teams is impossible.…”
Section: Discussionmentioning
confidence: 99%
“…In this article, the impact of stem cell/gene therapy in the neonate will not be discussed and what the future holds is yet to be seen (50). However, AP patients have been suggested as one group for gene therapy (44).…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, as newer and more technologically innovative interventions, including the artificial placenta, appear on the horizon for management of infants with extreme prematurity, clinicians and parents will continue to make decisions in ethical "gray zones," in which reasonable people can disagree. 7 The purpose of this Commentary is to support clinicians seeking consistent strategies for counseling and SDM in the gray zone by exploring the moral and practical dimensions at the margin of gestational viability, with an emphasis on contemporary normative and empirical work. We focus on the resuscitation of infants with extreme prematurity in high-resource settings; extensive exploration of the moral landscape of decision-making for preterm infants born in low-resource settings is equally important, but beyond the scope of this brief review.…”
mentioning
confidence: 99%